Effects of Succinic Acid Supplementation on Stable Cell Line Growth, Aggregation, and IgG and IgA Production
- 7 September 2020
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 21 (10) , 990-996
Abstract
Background: Immunoglobulin (Ig) G is the most commonly used therapeutic antibodies. Recently, the interest in IgA antibodies to treat respiratory infectious diseases has been increasing. The reason for the inefficient use of IgA is recombinant antibody aggregation in cell culture, affecting the longevity and productivity of cell lines. Lactate is an important metabolite that affects the cultivation of stable cell lines producing monoclonal antibodies. Methods: In the present study, we investigated whether different combinations of succinic acid and micro-additives affect lactate production, which correlates with productivity. The effect of succinic acid substitution on productivity of cells producing IgG/IgA was analyzed using the static culture method in a six-well plate. Lactate was measured in supernatant of cell culture indirectly by using the activity of Lactate Dehydrogenase (LDH).A low lactate level was observed in cultivation medium supplemented with succinic acid or asparagine combined with some inorganic salts. Result: The results also demonstrated the effect of component supplementation on homogeneity, longevity, and productivity of cell culture. Supplementation of succinic acid eliminated cell aggregation and improved homogeneity of stable cell lines producing IgG and, especially, IgA. Conclusion: Overall, succinic acid supplementation to the culture medium has potential biotechnological applications in the production IgG and IgA.Keywords
Funding Information
- Ministry of science and higher education of Russian Federation (14.607.21.0177; RFMEFI60717X0177)
This publication has 24 references indexed in Scilit:
- A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSVJournal of Virology, 2013
- Metabolic signatures of GS‐CHO cell clones associated with butyrate treatment and culture phase transitionBiotechnology and Bioengineering, 2013
- Flux balance analysis of CHO cells before and after a metabolic switch from lactate production to consumptionBiotechnology and Bioengineering, 2012
- Metabolic flux analysis of CHO cells at growth and non-growth phases using isotopic tracers and mass spectrometryMetabolic Engineering, 2011
- Aggregates in monoclonal antibody manufacturing processesBiotechnology and Bioengineering, 2011
- Metabolic flux analysis of CHO cell metabolism in the late non‐growth phaseBiotechnology and Bioengineering, 2010
- Expression systems for therapeutic glycoprotein productionCurrent Opinion in Biotechnology, 2009
- Quantitation of Aggregate Levels in a Recombinant Humanized Monoclonal Antibody Formulation by Size-Exclusion Chromatography, Asymmetrical Flow Field Flow Fractionation, and Sedimentation VelocityJournal of Pharmaceutical Sciences, 2007
- Protein aggregation and bioprocessingThe AAPS Journal, 2006
- Protein aggregation and its inhibition in biopharmaceuticsInternational Journal of Pharmaceutics, 2005